Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...
Federally funded research in mice shows neurons regulate osteosarcoma progression, suggesting that inhibiting nerve signaling ...
According to study co-lead author Qizhi Qin, Ph.D., a postdoctoral fellow in the James Laboratory, the researchers also found ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, researchers ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
Neuropathic pain is highly prevalent after spinal cord injury, with prevalence unrelated to severity of injury.
TipRanks on MSN
Nervgen Pharma’s NVG-291 Study: A Potential Breakthrough in Spinal Cord Injury Treatment
Nervgen Pharma Corp (($NGENF)) announced an update on their ongoing clinical study. Nervgen Pharma Corp is conducting an important clinical study ...
Blocking a small RNA molecule called miR-140-3b can improve motor function in a mouse model of SMA, a study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results